Our recent study, performed in a mouse model of melanoma, has investigated the potential role of β3-ARs in immune-tolerance regulation, evaluating the effect of β-AR blockade on the number and activity of immune cell subpopulations (Treg, NK, CD8, MDSC, macrophages, and neutrophils). Here, ADRB2 is linked to melanoma.